$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07D-487/22
  • C07F-005/00
출원번호 US-0320293 (1989-03-06)
발명자 / 주소
  • Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Nagara JPX)
출원인 / 주소
  • Board of Regents, The University of Texas System (Austin TX 02)
인용정보 피인용 횟수 : 128  인용 특허 : 0

초록

The present invention involves a novel tripyrrole dimethine-derived “expanded porphyrin”(texaphyrin), the synthesis of such compounds, their analogs or derivatives and their uses. These expanded porphyrin-like macrocycles are efficient chelators of divalent and trivalent metal ions. Metal complexes

대표청구항

A compound having the structure: [Figure] wherein R and R′are independently CH3; H or OCH3; and wherein M is a trivalent metal ion and n is 2.

이 특허를 인용한 특허 (128)

  1. Hilger Christoph Stephan,DEX ; Maier Franz Karl,DEX ; Gries Heinz,DEX ; Niedballa Ulrich,DEX ; Platzek Johannes,DEX ; Lee-Vaupel Mary,DEX ; Ebert Wolfgang,DEX ; Conrad Jurgen,DEX ; Gaida Josef,DEX, 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical agents containing the latter and process for their product.
  2. Gold, David V.; Goldenberg, David M., Anti-mucin antibodies for early detection and treatment of pancreatic cancer.
  3. Gold, David V.; Goldenberg, David M., Anti-mucin antibodies for early detection and treatment of pancreatic cancer.
  4. Gold, David V.; Goldenberg, David M., Anti-mucin antibodies for early detection and treatment of pancreatic cancer.
  5. Liu, Donglin; Gold, David V.; Chang, Chien-Hsing; Govindan, Serengulam V.; Goldenberg, David M., Anti-mucin antibodies for early detection and treatment of pancreatic cancer.
  6. Liu, Donglin; Gold, David V.; Chang, Chien-Hsing; Govindan, Serengulam V.; Goldenberg, David M., Anti-mucin antibodies for early detection and treatment of pancreatic cancer.
  7. Liu, Donglin; Chang, Chien-Hsing; Goldenberg, David M., Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2).
  8. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  9. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  10. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  11. Horowitz Bernard ; Williams Bolanle ; Margolis-Nunno Henrietta ; Chin Sing N., Biological compositions containing quenchers of type I and type II photodynamic reactions.
  12. Chang, James N.; Hughes, Patrick M.; Devries, Gerald W., Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems.
  13. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent (Austin TX), Chromophore probe for detection of nucleic acid.
  14. Govindan, Serengulam V.; Goldenberg, David M., Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy.
  15. Govindan, Serengulam V.; Goldenberg, David M., Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy.
  16. Govindan, Serengulam V.; Goldenberg, David M., Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy.
  17. Govindan, Serengulam V.; Goldenberg, David M., Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy.
  18. Hughes, Patrick M.; Olejnik, Orest; Whitcup, Scott M.; Burke, James A., Compositions and methods for localized therapy of the eye.
  19. Trogden, John T.; Salameh, Adnan K.; Pujara, Chetan P., Compositions and methods for stimulating hair growth.
  20. Sessler,Jonathan L.; Seidel,Daniel; Bolze,Frederic R.; Koehler,Thomas, Cyclo[n]pyrroles and methods thereto.
  21. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent L. (Austin TX) Sansom Petra I. (Austin TX) Wright Meredith (San Jose CA), DNA photocleavage using texaphyrins.
  22. Gold, David V.; Goldenberg, David M., Detection of early-stage pancreatic adenocarcinoma.
  23. Gold, David V.; Goldenberg, David M., Detection of early-stage pancreatic adenocarcinoma.
  24. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A.; Rossi, Diane, Disease therapy by inducing immune response to Trop-2 expressing cells.
  25. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A.; Rossi, Diane, Disease therapy by inducing immune response to Trop-2 expressing cells.
  26. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A.; Rossi, Diane, Disease therapy by inducing immune response to Trop-2 expressing cells.
  27. Pandey,Ravindra K.; Dougherty,Thomas J.; Pallenberg,Alexander J., Efficient synthesis of pyropheophorbide a and its derivatives.
  28. Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Gifu JPX), Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles and methods for treating tumors.
  29. Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA) Kral Vladimir A. (Austin TX) Magda Darren (Cupertino CA), Fluoresence detection using texaphyrins.
  30. Pandey, Ravindra K.; Potter, William R.; Dougherty, Thomas J., Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy.
  31. Pandey,Ravindra K.; Potter,William R.; Dougherty,Thomas J., Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy.
  32. Madden, Hugo; Hemmi, Greg; Mody, Tarak, High-purity texaphyrin metal complexes.
  33. Sessler Jonathan L. ; Allen William E. ; Kral Vladimir A.,CZX, Highly boronated derivatives of texaphyrins.
  34. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related implants.
  35. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  36. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  37. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  38. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  39. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  40. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  41. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  42. Hughes, Patrick M., Hypotensive prostamide-containing biodegradable intraocular implants and related methods.
  43. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michele, Intraocular biodegradable microspheres.
  44. Robinson, Michael R.; Blanda, Wendy M.; Hughes, Patrick M.; Ruiz, Guadalupe; Orilla, Werhner C.; Whitcup, Scott M.; Welty, Devin F.; Lin, Joan-En; Spada, Lon T., Intraocular drug delivery systems.
  45. Hughes, Patrick M., Intraocular pressure reduction with intracameral bimatoprost implants.
  46. Spada, Lon T.; Shiah, Jane Guo; Hughes, Patrick; Malone, Thomas C.; Devries, Gerald W.; Edelman, Jeffrey L.; Wurster, Julie A.; Guo, Xialing; Boral, Sougato, Kinase inhibitors.
  47. Petersen J. R. ; Abubaker Mohammad Amin ; Bissell M. G., Lanthanide metal cations for concurrent detection and separation in capillary electrophoresis.
  48. Stuart W. Young ; Meredith Wright ; Jonathan L. Sessler ; Tarak D. Mody ; Darren Magda, Membrane incorporation of texaphyrins.
  49. Bruckner Christian,CAX ; Boyle Ross W.,CAX ; Dolphin David,CAX, Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same.
  50. Bruckner Christian,CAX ; Boyle Ross W.,GBX ; Dolphin David,CAX, Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same.
  51. Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Mody Tarak D. (Austin TX), Metal complexes of water soluble texaphyrins.
  52. Hemmi Gregory W. ; Rosingana Miguel, Metallation of macrocycles with 2,4-dicarbonyl-metal complexes.
  53. Mody, Tarak D.; Galanter, Joshua, Metallotexaphyrin derivatives.
  54. Mody,Tarak D.; Galanter,Joshua, Metallotexaphyrin derivatives.
  55. Wai Chien M. ; Smart Neil G.,GBX ; Phelps Cindy, Method for separating metal chelates from other materials based on solubilities in supercritical fluids.
  56. Sessler Jonathan L. ; Iverson Brent L. ; Kral Vladimir ; Shreder Kevin ; Furuta Hiroyuki,JPX ; Thomas Richard E., Method for separating molecules.
  57. Richter Anna M.,CAX ; Waterfield Elizabeth,CAX ; Levy Julia G.,CAX, Method of activating photosensitive agents.
  58. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid.
  59. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michèle, Method of making tyrosine kinase microspheres.
  60. Magda Darren ; Sessler Jonathan L. ; Wright Meredith ; Miller Richard A. ; Dow William C., Method of phosphate ester hydrolysis.
  61. Young Stuart W. ; Miller Richard A., Methods for cancer chemosensitization.
  62. Hemmi Gregory W. (Sunnyvale CA) Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA), Methods of MRI enhancement using compounds having improved functionalization.
  63. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Methods of treating ocular disease using steroid-containing sustained release intraocular implants.
  64. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Microparticles manufactured in an oil-in-water process comprising a prostamide.
  65. Pandey, Ravindra K.; Goswami, Lalit; Spernyak, Joseph; Kanter, Peter; Mazurchuk, Richard, Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents.
  66. Mody,Tarak D.; Galanter,Joshua, Non-symmetric tripyrranes in the synthesis of novel macrocycles.
  67. Chen, James, Noninvasive vascular therapy.
  68. Chen,James, Noninvasive vascular therapy.
  69. Magda Darren ; Crofts Shaun P. ; Wright Meredith, Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof.
  70. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and prostamide.
  71. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  72. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  73. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  74. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  75. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  76. Lyons, Robert T.; Robinson, Michael R.; Trogden, John T.; Whitcup, Scott M., Peripherally administered viscous formulations.
  77. Whitcup, Scott M.; Robinson, Michael R.; Lyons, Robert T.; Trogden, John T., Peripherally administered viscous formulations.
  78. Lyons, Robert T.; Chang, James N.; Trogden, John T.; Whitcup, Scott, Pharmaceutical compositions.
  79. Sessler Jonathan L. ; Mody Tarak D. ; Hemmi Gregory W., Pharmaceutical compositions comprising texaphyrins.
  80. Magda Darren ; Sessler Jonathan L. ; Crofts Shaun P., Phosphoramidite derivatives of macrocycles.
  81. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent L. (Austin TX) Sansom Petra I. (Austin TX) Crofts Shaun P. (Campbell CA), Phosphoramidite derivatives of texaphyrins.
  82. Voet, Martin A., Photodynamic therapy for pre-melanomas.
  83. Woodburn Kathryn W. ; Fan Qing ; Young Stuart W., Photodynamic therapy of pigment-related lesions.
  84. Matthews J. Lester (Dallas TX) Judy Millard M. (Dallas TX) Newman Joseph T. (Dallas TX) Sogandares-Bernal Frank (Dallas TX) Sessler Jonathan L. (Austin TX) Harriman Anthony (Austin TX) Maiya Bhaskar , Photodynamic viral deactivation with sapphyrins.
  85. Thetford Dean (Manchester GB2) Gregory Peter (Bolton GB2), Poly-substituted phthalocyanines.
  86. Thetford Dean,GB2 ; Gregory Peter,GB2, Poly-substituted phthalocyanines.
  87. Horowitz Bernard ; Williams Bolanle ; Margolis-Nunno Henrietta ; Chin Sing N., Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodyn.
  88. Horowitz Bernard ; Williams Bolanle ; Margolis-Nunno Henrietta ; Chin Sing N., Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photod.
  89. Sessler Jonathan L. ; Harriman Anthony,FRX ; Miller Richard A. ; Magda Darren ; Mody Tarak D. ; Hemmi Gregory W., Radiation sensitization using texaphyrins.
  90. Sessler Jonathan L. (Austin TX) Kral Vladimir (Austin TX) Andrievsky Andrei (Austin TX), Sapphyrin multimers.
  91. Zhang, Xiao-An; Jasanoff, Alan Pradip; Lippard, Stephen J., Sensors for fluorescence and magnetic resonance imaging.
  92. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  93. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  94. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  95. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  96. Burke, James; Hughes, Patrick M.; Werhner, Orilla C.; Lin, Ton C.; Escobar, Maria; Huang, Glenn; Zhang, Kai-Ming; Wheeler, Larry A.; Donn, Rosy S., Sustained release intraocular implants and methods for preventing retinal dysfunction.
  97. Huang, Glenn T.; Burke, James A.; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Sheng, Rosy, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  98. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  99. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  100. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and methods for treating ocular neuropathies.
  101. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  102. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  103. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  104. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  105. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  106. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  107. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  108. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  109. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  110. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  111. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  112. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffrey L.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  113. Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Edelman, Jeffrey L.; Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  114. Bruckner Christian,CAX ; Boyle Ross W.,GB2 ; Dolphin David,CAX, Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds.
  115. Hemmi Gregory W. (Sunnyvale CA) Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA), Texaphyrin complexes having improved functionalization.
  116. Hemmi Gregory W. (Sunnyvale CA) Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA), Texaphyrin compounds having improved functionalization.
  117. Magda, Darren; Miles, Dale; Gerasimchuk, Nikolay; Lepp, Cheryl, Texaphyrin coordination compounds and uses thereof.
  118. Sessler Jonathan L. (Austin TX) Hemmi Gregory W. (Austin TX) Murai Toshiaki (Gifu JPX), Texaphyrin macrocycles and metal complexes thereof.
  119. Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA), Texaphyrin metal complexes having improved functionalization.
  120. Sessler Jonathan L. (Austin TX) Iverson Brent L. (Austin TX) Kral Vladimir (Austin TX) Thomas Richard E. (Chesapeake VA) Magda Darren (Cupertino CA) Smith Daniel A. (Goshen IN), Texaphyrin solid supports and devices.
  121. Sessler Jonathan L. (Austin TX) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyvale CA) Kral Vladimir A. (Austin TX) Magda Darren (Cupertino CA), Texaphyrin-oligonucleotide conjugates.
  122. Magda Darren (Cupertino CA) Sessler Jonathan L. (Austin TX) Iverson Brent (Austin TX) Jansen Petra L. (Austin TX) Wright Meredith (San Jose CA) Mody Tarak D. (Sunnyvale CA) Hemmi Gregory W. (Sunnyval, Texaphyrins and uses thereof.
  123. Sessler Jonathan L. ; Hemmi Gregory W. ; Mody Tarak D. ; Magda Darren ; Kral Vladimir A.,CZX, Texaphyrins substituted with imidazole are provided.
  124. Bodaness Richard S. (5225 Pooks Hill Rd. Apt. 1603-South Bethesda MD 20814), Two-step cancer treatment method.
  125. Wai,Chien M.; Enokida,Youichi, Ultrasound enhanced process for extracting metal species in supercritical fluids.
  126. Woodburn Kathryn W. ; Young Stuart W., Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma.
  127. Pandey, Ravindra K.; Gryshuk, Amy; Goswami, Lalit; Potter, William; Oseroff, Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  128. Pandey,Ravindra K.; Gryshuk,Amy; Goswami,Lalit; Potter,William; Oseroff,Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로